Example report
Does selenium supplementation prevent cancer?
Generated on 26 September 2026
Bottom Line
Well-designed and well-conducted RCTs have shown no beneficial effect of selenium supplements in reducing cancer risk (high certainty of evidence). For analyses of RCTs with low risk of bias, the summary risk ratio (RR) for any cancer incidence was 1.01 (95% confidence interval (CI) 0.93 to 1.10; 3 studies, 19,475 participants; high-certainty evidence). (S1)
Cochrane (2018) rated this evidence high certainty.
The registry also contains 2 later systematic reviews or guidelines on this question (latest 2023). They are not summarised here; see the full list in Research Rail.
Sources
This report screened 46 items (43 research or guidance records, 3 community posts); the full list is available in Research Rail.